The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,123.00
Bid: 1,100.00
Ask: 1,320.00
Change: 0.00 (0.00%)
Spread: 220.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,123.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Governance Changes

15 Aug 2019 15:38

RNS Number : 2369J
Burford Capital Limited
15 August 2019
 

 

This announcement contains inside information.

 

15 August 2019

 

BURFORD CAPITAL ANNOUNCES GOVERNANCE CHANGES

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and investment management firm focused on law, today issued the following statement regarding the evolution of its corporate governance.

 

Burford's Listing

 

Burford has made it clear for some time that it is considering an expansion of its stock market listing and that it is exploring a dual listing in the US.

 

Investors have asked for more clarity and granularity around our plans. Investors have also made it clear that they do not support Burford remaining solely AIM listed. We have listened and, while we were already taking action, as reflected in past disclosure, we set out here our plans and our commitments.

 

Burford has concluded that it will endeavour to procure a second listing on either NASDAQ or the NYSE as a first choice. We believe that the deep liquidity in those markets, as well as the opportunity to access a broad pool of US investors who do not today invest in litigation finance but are generally familiar with US litigation, makes a US listing commercially attractive as an alternative to moving Burford's current listing to the LSE Main Market. A US listing would come with applicable disclosure and governance obligations.

 

We are in fact already engaged in the early stages of the process to seek a US listing, and have been since well before recent events. There are some preliminary legal matters to resolve, given that there has never been a litigation finance provider listed in the US, and that process may take several months. Thereafter, the usual SEC registration statement process will need to be completed. Our hope would be that we could complete the process by the end of the first quarter of 2020 or as soon as reasonably practicable thereafter, although that timetable cannot be assured.

 

If we determine that there is an insuperable challenge with achieving a US listing, then we intend to pursue a premium listing on the LSE Main Market.

 

Burford's Board of Directors

 

Burford's Board is comprised of four directors who have served in those roles since Burford's IPO in 2009. Collectively, they represent an enormous wealth of talent and experience both in the intersection of law and finance, and in the development of the litigation finance industry, and we believe that they serve the interests of shareholders well.

 

However, we have listened and defer to the wishes of our shareholders and therefore we are taking the following initial steps with respect to the Board.

 

We are commencing a formal search to add two new independent directors to the Board as rapidly as possible.

 

Once those new directors are in place, we will operate a period of overlap with the existing directors. Then, David Lowe will leave the board at the next AGM and Sir Peter Middleton will leave the board at the following AGM. We also intend that in terms of management representation, at least the Chief Executive Officer ("CEO") will join the board in due course.

 

We anticipate further evolution of the Board but the specifics of that evolution are bound up with the ultimate listing destination and its governance rules, and we will report further on the next step in Board evolution as appropriate.

 

Burford's Chief Financial Officer

 

Concern has been raised about the fact that Burford's CEO and Chief Financial Officer ("CFO") are married. We believe that concern is unjustified given Burford's control structure and ignores Burford's finance and accounting structure.

 

Nevertheless, it is clear that investors would prefer an alternative CFO, and thus Burford announces that, with immediate effect, Jim Kilman will take on the role of CFO to buttress confidence in Burford's financial disclosures and to guide the Company through the change in its listing discussed above. Mr. Kilman was most recently Vice Chairman of Morgan Stanley Investment Banking and has spent his career in the specialty finance industry. Mr. Kilman knows Burford well, having been its principal investment banker at Morgan Stanley, and has been serving as a senior adviser to Burford since his departure from Morgan Stanley in 2016 among numerous other activities. Mr. Kilman has agreed to serve for up to two years as CFO and the Board, once reconstituted as discussed above, will take up succession planning for the CFO role as a priority.

 

Charles Utley will continue to serve as Burford's Chief Accounting Officer. Mr. Utley is an English accountant with a long-standing career, most recently from Barclays, where he spent 11 years in senior technical accounting roles including with respect to the valuation of illiquid assets and before that spent eight years at PwC, and he has key involvement in the preparation of Burford's accounts (including its investment valuation process) and engagement with Burford's auditors.

 

Ms. O'Connell will become Burford's Chief Strategy Officer so that Burford can continue to benefit from her long and deep knowledge of the business and the Board expresses its gratitude to her for her service and her flexibility. Ms. O'Connell will be fully available to assist Mr. Kilman as he assumes the CFO role.

 

Sir Peter Middleton GCB, Chairman of Burford, commented:

 

"Companies are owned by their shareholders, and when the shareholders speak, it is the role of boards and management to listen. While we may take a different view on some of these points, shareholders have clearly spoken and we have listened, just as Burford has throughout its existence. We trust that these governance enhancements operate to bolster investor confidence in Burford as it enters its next era of growth and success."

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Christopher Bogart, Chief Executive Officer.

 

 

For further information, please contact:

 

Burford Capital Limited

Christopher Bogart, Chief Executive Officer

+1 212 235 6825

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Alex Reynolds

Liberum Capital Limited - Joint Broker

+44 (0)20 3100 2222

Richard Crawley

Jamie Richards

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Jonathan Abbott

Montfort Communications Limited - Financial Communications

+44 (0)20 3770 7908

Robert Bailhache - email

 

 

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund.  Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRPAMITMBJBBFL
Date   Source Headline
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.